Robinson Chandler

CIK 00017273341 companyWILMETTE, IL

SEC Profile

Transactions

Companies

Filings

CIK

0001727334

Recent Transactions

50 trades

Exercise/Conversion
Monopar Therapeutics$MNPR
Restricted Stock Unit
2025-12-31−8,724→ 113,008 total
Tax Payment
Monopar Therapeutics$MNPR
Common Stock
2025-12-31$65.30/sh−2,558→ 85,718 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Common Stock
2025-12-31+8,724→ 88,276 total
Award
Monopar Therapeutics$MNPR
Stock Options
2025-12-02+16,753→ 16,753 total
Award
Monopar Therapeutics$MNPR
Restricted Stock Units
2025-12-02+49,133→ 121,732 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Restricted Stock Units
2025-09-30−8,726→ 72,599 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Common Stock
2025-09-30+8,726→ 82,198 total
Tax Payment
Monopar Therapeutics$MNPR
Common Stock
2025-09-30$81.67/sh−2,646→ 79,552 total
Exercise of In-Money
Monopar Therapeutics$MNPR
Stock Options
2025-07-14−16,800→ 0 total
Sale
Monopar Therapeutics$MNPR
Common Stock
2025-07-14$40.00/sh−16,800→ 73,472 total
Exercise of In-Money
Monopar Therapeutics$MNPR
Common Stock
2025-07-14$0.01/sh+16,800→ 90,272 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Restricted Stock Units
2025-06-30−13,344→ 81,325 total
Tax Payment
Monopar Therapeutics$MNPR
Common Stock
2025-06-30$35.78/sh−5,865→ 73,472 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Common Stock
2025-06-30+13,344→ 79,337 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Common Stock
2025-03-31+4,106→ 67,197 total
Tax Payment
Monopar Therapeutics$MNPR
Common Stock
2025-03-31$36.41/sh−1,204→ 65,993 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Restricted Stock Units
2025-03-31−4,106→ 94,669 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Common Stock
2025-03-04+6,002→ 64,850 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Restricted Stock Units
2025-03-04−6,002→ 98,775 total
Award
Monopar Therapeutics$MNPR
Stock Options
2025-03-04+85,759→ 85,759 total
Tax Payment
Monopar Therapeutics$MNPR
Common Stock
2025-03-04$31.70/sh−1,759→ 63,091 total
Award
Monopar Therapeutics$MNPR
Restricted Stock Units
2025-03-04+79,899→ 104,777 total
Other
Monopar Therapeutics$MNPR
Common Stock
2025-01-28+62,815→ 62,815 total
Tax Payment
Monopar Therapeutics$MNPR
Common Stock
2024-12-31$22.00/sh−2,209→ 58,848 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Restricted Stock Units
2024-12-31−4,895→ 24,879 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Common Stock
2024-12-31+4,895→ 61,057 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Restricted Stock Units
2024-09-30−4,895→ 29,774 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Common Stock
2024-09-30+4,895→ 58,080 total
Tax Payment
Monopar Therapeutics$MNPR
Common Stock
2024-09-30$6.74/sh−1,918→ 56,162 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Common Stock
2024-06-30+24,476→ 274,606.8 total
Tax Payment
Monopar Therapeutics$MNPR
Common Stock
2024-06-30$0.73/sh−8,684→ 265,922.8 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Restricted Stock Units
2024-06-30−24,476→ 173,335 total
Exercise of In-Money
Monopar Therapeutics$MNPR
Common Stock
2024-05-28$0.00/sh+84,000→ 250,130.8 total
Exercise of In-Money
Monopar Therapeutics$MNPR
Stock Options
2024-05-28−84,000→ 0 total
Tax Payment
Monopar Therapeutics$MNPR
Common Stock
2024-03-31$0.68/sh−7,172→ 166,130.8 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Restricted Stock Units
2024-03-31−24,474→ 197,811 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Common Stock
2024-03-31+24,474→ 173,302.8 total
Tax Payment
Monopar Therapeutics$MNPR
Common Stock
2024-01-01$0.34/sh−2,327→ 148,828.8 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Restricted Stock Units
2024-01-01−6,724→ 222,285 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Common Stock
2024-01-01+6,724→ 151,155.8 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Restricted Stock Units
2023-12-31−24,474→ 229,009 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Common Stock
2023-12-31+24,474→ 152,900.8 total
Tax Payment
Monopar Therapeutics$MNPR
Common Stock
2023-12-31$0.34/sh−8,469→ 144,431.8 total
Tax Payment
Monopar Therapeutics$MNPR
Common Stock
2023-09-30$0.62/sh−7,172→ 128,426.8 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Common Stock
2023-09-30+24,474→ 135,598.8 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Restricted Stock Units
2023-09-30−24,474→ 253,483 total
Tax Payment
Monopar Therapeutics$MNPR
Common Stock
2023-06-30$0.85/sh−10,269→ 111,124.8 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Restricted Stock Units
2023-06-30−35,039→ 277,957 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Common Stock
2023-06-30+35,039→ 121,393.8 total
Tax Payment
Monopar Therapeutics$MNPR
Common Stock
2023-03-31$1.39/sh−4,286→ 86,354.8 total

Companies

Monopar Therapeutics
Director, Chief Executive Officer
$MNPR

Recent Filings

Address

1000 SKOKIE BLVD SUITE 350

WILMETTE, IL, 60091

View on SEC.gov